243 related articles for article (PubMed ID: 31246271)
1. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
[No Abstract] [Full Text] [Related]
2. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
3. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
Lee WC; Fang HY; Fang CY
Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
[No Abstract] [Full Text] [Related]
4. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
[No Abstract] [Full Text] [Related]
5. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
[No Abstract] [Full Text] [Related]
6. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
[TBL] [Abstract][Full Text] [Related]
7. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.
McCutcheon K; Bennett J; Marynissen T; Adriaenssens T
Acta Cardiol; 2020 Feb; 75(1):85-86. PubMed ID: 30735472
[No Abstract] [Full Text] [Related]
8. Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography.
Seo J; Kim Y; Kim BK; Hong SJ; Ahn CM; Kim JS; Cho DK; Ko YG; Choi D; Hong MK; Jang Y
Cardiol J; 2020; 27(2):208-209. PubMed ID: 32463107
[No Abstract] [Full Text] [Related]
9. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
[No Abstract] [Full Text] [Related]
10. Very early in-stent neoatherosclerosis assessed by optical coherence tomography.
Vergara-Martel A; Pizzato PE; Dallan LAP; Pereira GTR; Richmond HCT; Attizzani GF; Jones MR
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1793-1794. PubMed ID: 31175526
[No Abstract] [Full Text] [Related]
11. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
12. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
[No Abstract] [Full Text] [Related]
13. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
[No Abstract] [Full Text] [Related]
14. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
Sato T; Richardt G; Abdel-Wahab M
Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
[No Abstract] [Full Text] [Related]
15. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
Granata F; Moscarella E; Varricchio A
Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
[No Abstract] [Full Text] [Related]
16. Bioresorbable scaffolds for the treatment of in-stent restenosis.
Dörr O; Liebetrau C; Wiebe J; Hecker F; Rixe J; Möllmann H; Hamm C; Nef H
Heart Vessels; 2015 Mar; 30(2):265-9. PubMed ID: 24390727
[TBL] [Abstract][Full Text] [Related]
17. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
[TBL] [Abstract][Full Text] [Related]
18. Very late scaffold thrombosis: insights from optical coherence tomography and histopathology.
Joner M; Nicol P; Rai H; Richter H; Foin N; Ng J; Cuesta J; Rivero F; Serrano R; Alfonso F
EuroIntervention; 2018 Apr; 13(18):e2169-e2173. PubMed ID: 29155382
[No Abstract] [Full Text] [Related]
19. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
20. Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
Rheude TA; Xhepa E; Byrne RA
Catheter Cardiovasc Interv; 2017 May; 89(6):E181-E184. PubMed ID: 27527355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
